BOUNDS GREEN GROUP PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: F85066 | LONDON, N11 2PF
Showing results 401-450 of 673
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 46 | 2,460 | £7.8K | +105.3% ▲ | |
| Sennosides | 45 | 20.8K | £387 | +45.7% ▲ |
| Rifaximin | 45 | 676 | £3.0K | +67.6% ▲ |
| Leuprorelin acetate | 45 | 45 | £10.2K | -2.9% ▼ |
| Metronidazole | 45 | 1,815 | £712 | +19.7% ▲ |
| 44 | 1,453 | £978 | -35.8% ▼ | |
| Sodium picosulfate | 43 | 12.7K | £1.0K | +18.5% ▲ |
| Dutasteride | 43 | 2,818 | £163 | -16.3% ▼ |
| Medroxyprogesterone acetate | 43 | 43 | £246 | -64.4% ▼ |
| Febuxostat | 43 | 826 | £133 | +15.1% ▲ |
| Latanoprost and timolol | 43 | 933 | £531 | -43.7% ▼ |
| Insulin Lispro | 42 | 252 | £1.6K | -45.1% ▼ |
| 42 | 129 | £964 | +50.9% ▲ | |
| 41 | 8,672 | £324 | -17.8% ▼ | |
| Tinzaparin sodium | 40 | 1,422 | £10.3K | +170.1% ▲ |
| Pramipexole | 40 | 2,156 | £999 | -59.3% ▼ |
| Other compound vitamin/mineral formulation preparations | 40 | 3,332 | £254 | +24.8% ▲ |
| Heparinoid | 40 | 5,000 | £274 | +52.5% ▲ |
| Glyceryl trinitrate | 38 | 1,200 | £1.5K | +186.0% ▲ |
| Clobazam | 38 | 786 | £92 | -42.4% ▼ |
| Trazodone hydrochloride | 37 | 1,998 | £122 | -81.9% ▼ |
| Ciprofloxacin | 37 | 789 | £122 | -7.2% ▼ |
| Biphasic insulin lispro | 37 | 345 | £2.1K | -13.8% ▼ |
| 37 | 3,915 | £430 | +83.0% ▲ | |
| Bempedoic acid | 36 | 336 | £636 | +9.8% ▲ |
| Menthol | 36 | 15.6K | £570 | +27.8% ▲ |
| Ivermectin | 36 | 1,680 | £977 | +69.3% ▲ |
| 36 | 3,937 | £7.5K | +6.6% ▲ | |
| Pizotifen malate | 35 | 1,568 | £68 | -57.5% ▼ |
| Anastrozole | 35 | 2,072 | £78 | -61.6% ▼ |
| Mupirocin | 35 | 123 | £166 | +198.1% ▲ |
| Bezafibrate | 34 | 1,932 | £459 | -36.9% ▼ |
| Ipratropium bromide | 34 | 1,002 | £414 | +18.3% ▲ |
| Domperidone | 34 | 1,539 | £33 | -4.7% ▼ |
| Amantadine hydrochloride | 34 | 4,264 | £2.3K | +22.1% ▲ |
| Mebendazole | 34 | 596 | £40 | +197.0% ▲ |
| Dulaglutide | 34 | 192 | £3.5K | -70.3% ▼ |
| Medroxyprogesterone acetate | 34 | 1,663 | £322 | -11.2% ▼ |
| Telmisartan | 33 | 1,400 | £200 | -43.1% ▼ |
| Powder extensively hydrolysed formula (0913101) | 33 | 69.6K | £1.9K | -54.2% ▼ |
| Brimonidine tartrate | 33 | 300 | £252 | -17.3% ▼ |
| 33 | 870 | £1.8K | -11.1% ▼ | |
| Crotamiton | 32 | 4,120 | £250 | +92.4% ▲ |
| Alkyl sulphate | 32 | 7,788 | £208 | +246.3% ▲ |
| Heparinoid | 32 | 3,200 | £243 | +145.4% ▲ |
| 32 | 4,820 | £499 | -33.6% ▼ | |
| 32 | 1,810 | £242 | -60.2% ▼ | |
| Olmesartan medoxomil/amlodipine | 31 | 1,120 | £644 | +135.0% ▲ |
| Temazepam | 31 | 1,223 | £956 | -45.8% ▼ |
| Dosulepin hydrochloride | 31 | 2,828 | £608 | -45.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.